Facebook
Linkedin
Tumblr
Twitter
Sign in
My Account
orders
Sign in
Welcome!
Log into your account
your username
your password
Forgot your password?
Password recovery
Recover your password
your email
Search
Sign in / Join
Facebook
Linkedin
Tumblr
Twitter
Sign in
Welcome! Log into your account
your username
your password
Forgot your password? Get help
Password recovery
Recover your password
your email
A password will be e-mailed to you.
Market Exclusive
My Account
orders
Home
Tags
NYSE:ABBV
Tag: NYSE:ABBV
Merck & Co., Inc. (NYSE:MRK) In $2.9 Billion Writedown After Market...
Andy Parker
-
February 24, 2017
0
AbbVie Inc (NYSE:ABBV) In Share Buyback Plan For The Third Year...
-
February 21, 2017
0
UK National Institute For Health And Care Excellence Rejects Leukemia Drug...
Andy Parker
-
February 16, 2017
0
ABBVIE INC. (NYSE:ABBV) Files An 8-K Results of Operations and Financial...
ME Staff 8-k
-
January 27, 2017
0
Here’s What’s Important About The Latest AbbVie Inc (NYSE:ABBV) Approval
-
January 20, 2017
0
Emergent Technologies’ Pure MHC Explores A New Collaboration With AbbVie Inc...
Andy Parker
-
January 10, 2017
0
ABBVIE INC. (NYSE:ABBV) Files An 8-K Departure of Directors or Certain...
ME Staff 8-k
-
January 9, 2017
0
Mylan NV (NASDAQ:MYL), AbbVie Inc (NYSE:ABBV) Sanofi SA (NYSE:SNY) In Spotlight...
Andy Parker
-
January 3, 2017
0
AbbVie Inc (NYSE:ABBV) Awaits NDA Approval For Hepatitis C Treatment
Andy Parker
-
December 21, 2016
0
Gilead Sciences, Inc. (NASDAQ:GILD) Takes Lead Against AbbVie Inc (NYSE:ABBV) On...
-
November 29, 2016
0
1
...
9
10
11
...
13
Page 10 of 13